Biotechnology
Pharmaceutical
Biopharmaceutical

MannKind

10,024

$1.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.89%) As of 3:02 PM EDT today
-$0.02 (-1.89%) Today

Why Robinhood?

You can buy or sell MannKind and other stocks, options, ETFs, and crypto commission-free!

About MNKD

MannKind Corporation Common Stock, also called MannKind, is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. Read More The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.

CEO
Michael E. Castagna
Employees
233
Headquarters
Westlake Village, California
Founded
1991
Market Cap
225.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.89M
High Today
$1.08
Low Today
$1.02
Open Price
$1.06
Volume
870.09K
52 Week High
$2.01
52 Week Low
$0.80

Collections

Biotechnology
Pharmaceutical
Biopharmaceutical
Health

MNKD News

ReutersMar 24

BRIEF-Jennifer Grancio Appointed To MannKind Board Of Directors

March 24 (Reuters) - MannKind Corp: * JENNIFER GRANCIO APPOINTED TO MANNKIND BOARD OF DIRECTORS Source text for Eikon: Further company coverage:
21

MNKD Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, Pre-Market

People Also Bought

Geron

31,202

$1.12

+4.21%

Geron

31,202

$1.12

+4.21%

New Age Beverages

58,460

$1.32

-5.04%

Oragenics

53,539

$0.5549

-1.10%

India Globalization Capital

60,772

$0.5801

-3.06%

You May Also Like

JMEI
PNM
PGZ
ANGL
ZG
LOWC
PVAL
EKAR
STFC
SVVC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MNKD

Market Price$1.04
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MannKind stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up